We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 14
Most popular |Most recent

Health Care Companies Take Note: DOJ Ramps Up FCPA Enforcement

USA - September 1 2017 In July, we reported on Attorney General Sessions dismantling DOJ's Health Care Corporate Fraud Strike Force. On July 25, Sandra Moser, acting chief...

Alexander Hokenson, Stephen Weiss.

EpiPen Maker Mylan Gets Stuck With $465 Million Fine; Politicians Say it Doesn’t Sting Enough

USA - August 21 2017 After years of defrauding the U.S. government and taxpayers, Mylan, the maker of EpiPen, last week resolved allegations that it profited at the...

Stephen Weiss.

DOJ’s Focus on Health Care Fraud Continues

USA - June 2 2017 Combating health care fraud will continue to be a priority for the Jeff Sessions-led Department of Justice (DOJ). DOJ Criminal Division’s Acting...

Stephen Weiss, Brian T. McGovern.

Supreme Court Denies Appeal in DeCoster

USA - May 25 2017 The Supreme Court will not hear the most important Park doctrine case in over 40 years. In DeCoster v. United States, the DeCosters appealed their...

Stephen Weiss, Brian T. McGovern.

Looking to the U.S. Supreme Court for Clarity on the Responsible Corporate Officer Doctrine

USA - May 4 2017 The most important Park doctrine case in over forty years may be heading to the Supreme Court - but not if the federal government has its way. On...

Stephen Weiss, Brian T. McGovern.